324 related articles for article (PubMed ID: 18650091)
21. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
22. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
23. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
[TBL] [Abstract][Full Text] [Related]
24. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
[TBL] [Abstract][Full Text] [Related]
25. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies.
Sauer R; Sautter-Bihl ML; Budach W; Feyer P; Harms W; Souchan R; Wollwiener D; Kreienberg R; Wenz F
Cancer; 2007 Sep; 110(6):1187-94. PubMed ID: 17647249
[TBL] [Abstract][Full Text] [Related]
26. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
[TBL] [Abstract][Full Text] [Related]
27. Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?
Aziz MH; Schneider F; Clausen S; Blank E; Herskind C; Afzal M; Wenz F
Radiat Oncol; 2011 Dec; 6():174. PubMed ID: 22176703
[TBL] [Abstract][Full Text] [Related]
28. One-step intraoperative radiotherapy optimizes conservative treatment of breast cancer with advantages in quality of life and work resumption.
Sorrentino L; Fissi S; Meaglia I; Bossi D; Caserini O; Mazzucchelli S; Truffi M; Albasini S; Tabarelli P; Liotta M; Ivaldi GB; Corsi F
Breast; 2018 Jun; 39():123-130. PubMed ID: 29674010
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer.
Wong JHD; Zaili Z; Abdul Malik R; Bustam AZ; Saad M; Jamaris S; Mosiun JA; Mohd Taib NA; Ung NM; See MH
J Appl Clin Med Phys; 2021 Aug; 22(8):139-147. PubMed ID: 34254425
[TBL] [Abstract][Full Text] [Related]
30. A novel approach of INTRABEAM intraoperative radiotherapy for nipple-sparing mastectomy with breast reconstruction.
Pan L; Zheng W; Ye X; Chen L; Ke Y; Wan M; Tang W; Gao J; Zhang X
Clin Breast Cancer; 2014 Dec; 14(6):435-41. PubMed ID: 24985074
[TBL] [Abstract][Full Text] [Related]
31. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
[TBL] [Abstract][Full Text] [Related]
32. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative radiotherapy in early breast cancer.
Esposito E; Anninga B; Harris S; Capasso I; D'Aiuto M; Rinaldo M; Douek M
Br J Surg; 2015 May; 102(6):599-610. PubMed ID: 25787293
[TBL] [Abstract][Full Text] [Related]
34. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
[TBL] [Abstract][Full Text] [Related]
35. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
[TBL] [Abstract][Full Text] [Related]
37. [Firs Case Report of Intraoperative Radiotherapy (IORT) for Early Breast Cancer in Bulgaria].
Sedloev T; Gabrovski I; Usheva S; Kovacheva S; Spiridonova T; Spirdonov J; Jeleva Z; Terziev I; Korukov B; Damyanov D; Lövey G
Khirurgiia (Sofiia); 2016; 82(1):40-4. PubMed ID: 29383929
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan.
Jingu K; Tanabe T; Nemoto K; Ariga H; Umezawa R; Ogawa Y; Takeda K; Koto M; Sugawara T; Kubozono M; Shimizu E; Abe K; Yamada S
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e507-11. PubMed ID: 22445002
[TBL] [Abstract][Full Text] [Related]
39. Breast conserving surgery in combination with intraoperative radiotherapy after previous external beam therapy: an option to avoid mastectomy.
Thangarajah F; Heilmann J; Malter W; Kunze S; Marnitz S; Mallmann P; Wenz F; Sperk E
Breast Cancer Res Treat; 2018 Apr; 168(3):739-744. PubMed ID: 29335922
[TBL] [Abstract][Full Text] [Related]
40. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand].
Gatzemeier W; Orecchia R; Gatti G; Intra M; Veronesi U
Strahlenther Onkol; 2001 Jul; 177(7):330-7. PubMed ID: 11505618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
